{"transactions":[{"id":707193,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T21:00:07.000Z","date":"2026-03-31","kind":"other","planned":false,"acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"date","element":"transactionDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported grant was made in error and has been cancelled."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001683168-26-005622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826005622/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-02"}},{"id":707190,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T21:00:05.000Z","date":"2026-03-31","kind":"other","planned":false,"acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"date","element":"transactionDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported grant was made in error and has been cancelled."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001683168-26-005621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826005621/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-02"}},{"id":707189,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T21:00:03.000Z","date":"2026-03-31","kind":"other","planned":false,"acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"date","element":"transactionDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported grant was made in error and has been cancelled."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001683168-26-005620","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826005620/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-02"}},{"id":707188,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T21:00:02.000Z","date":"2026-03-31","kind":"other","planned":false,"acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"date","element":"transactionDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported grant was made in error and has been cancelled."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001683168-26-005619","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826005619/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-02"}},{"id":820571,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:17:39.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":119170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein."}],"balance_after":119170,"derivative":{"exercise_price":0.67,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":119170},"source":{"system":"sec-edgar","filing":"0001683168-26-002633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826002633/ownership.xml","form_type":"4"}},{"id":820570,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:17:24.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":119170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker."}],"balance_after":119170,"derivative":{"exercise_price":0.67,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":119170},"source":{"system":"sec-edgar","filing":"0001683168-26-002632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826002632/ownership.xml","form_type":"4"}},{"id":820569,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:17:06.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":119170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter."}],"balance_after":119170,"derivative":{"exercise_price":0.67,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":119170},"source":{"system":"sec-edgar","filing":"0001683168-26-002631","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826002631/ownership.xml","form_type":"4"}},{"id":820568,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:16:53.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":119170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis."}],"balance_after":119170,"derivative":{"exercise_price":0.67,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":119170},"source":{"system":"sec-edgar","filing":"0001683168-26-002630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826002630/ownership.xml","form_type":"4"}},{"id":944965,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-07T22:43:33.000Z","date":"2026-01-07","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":0.8329,"value":33316.0,"ownership":{"direct":true},"balance_after":416250,"source":{"system":"sec-edgar","filing":"0001683168-26-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000148/ownership.xml","form_type":"4"}},{"id":944964,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-07T22:43:33.000Z","date":"2026-01-06","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.7889,"value":23667.0,"ownership":{"direct":true},"balance_after":376250,"source":{"system":"sec-edgar","filing":"0001683168-26-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000148/ownership.xml","form_type":"4"}},{"id":944963,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-07T22:43:33.000Z","date":"2026-01-05","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.7831,"value":23493.0,"ownership":{"direct":true},"balance_after":346250,"source":{"system":"sec-edgar","filing":"0001683168-26-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000148/ownership.xml","form_type":"4"}},{"id":944962,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:43:16.000Z","date":"2026-01-07","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.8436,"value":16872.0,"ownership":{"direct":true},"balance_after":192500,"source":{"system":"sec-edgar","filing":"0001683168-26-000147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000147/ownership.xml","form_type":"4"}},{"id":944961,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:43:16.000Z","date":"2026-01-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.7904,"value":15808.0,"ownership":{"direct":true},"balance_after":172500,"source":{"system":"sec-edgar","filing":"0001683168-26-000147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000147/ownership.xml","form_type":"4"}},{"id":944960,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:43:16.000Z","date":"2026-01-05","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.7776,"value":15552.0,"ownership":{"direct":true},"balance_after":152500,"source":{"system":"sec-edgar","filing":"0001683168-26-000147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000147/ownership.xml","form_type":"4"}},{"id":971653,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T22:08:04.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":63233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein. This transaction is late due to an inadvertent administrative error and not any error of Mr. Weinstein."}],"balance_after":63233,"derivative":{"exercise_price":1.22,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":63233},"source":{"system":"sec-edgar","filing":"0001683168-25-009116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009116/ownership.xml","form_type":"4"}},{"id":971652,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:08:04.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":33750,"price":1.02,"value":34425.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":41250,"source":{"system":"sec-edgar","filing":"0001683168-25-009116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009116/ownership.xml","form_type":"4"}},{"id":971651,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:08:04.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001683168-25-009116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009116/ownership.xml","form_type":"4"}},{"id":971650,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T22:07:49.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":63233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker. This transaction is late due to an inadvertent administrative error and not any error of Mr. Walker."}],"balance_after":63233,"derivative":{"exercise_price":1.22,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":63233},"source":{"system":"sec-edgar","filing":"0001683168-25-009115","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009115/ownership.xml","form_type":"4"}},{"id":971649,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:07:49.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":16875,"price":1.02,"value":17212.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":20625,"source":{"system":"sec-edgar","filing":"0001683168-25-009115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009115/ownership.xml","form_type":"4"}},{"id":971648,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:07:49.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001683168-25-009115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009115/ownership.xml","form_type":"4"}},{"id":971644,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-12-12T22:07:33.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":258750,"price":1.02,"value":263925.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":316250,"source":{"system":"sec-edgar","filing":"0001683168-25-009114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009114/ownership.xml","form_type":"4"}},{"id":971643,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-12-12T22:07:33.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":575000,"source":{"system":"sec-edgar","filing":"0001683168-25-009114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009114/ownership.xml","form_type":"4"}},{"id":971647,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T22:07:16.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":63233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter."}],"balance_after":63233,"derivative":{"exercise_price":1.22,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":63233},"source":{"system":"sec-edgar","filing":"0001683168-25-009113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009113/ownership.xml","form_type":"4"}},{"id":971646,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:07:16.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":67500,"price":1.02,"value":68850.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":132500,"source":{"system":"sec-edgar","filing":"0001683168-25-009113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009113/ownership.xml","form_type":"4"}},{"id":971645,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:07:16.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001683168-25-009113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009113/ownership.xml","form_type":"4"}},{"id":971642,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T22:06:55.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":63233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis."}],"balance_after":63233,"derivative":{"exercise_price":1.22,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":63233},"source":{"system":"sec-edgar","filing":"0001683168-25-009112","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009112/ownership.xml","form_type":"4"}},{"id":971641,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:06:55.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":16875,"price":1.02,"value":17212.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":22292,"source":{"system":"sec-edgar","filing":"0001683168-25-009112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009112/ownership.xml","form_type":"4"}},{"id":971640,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:06:55.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39167,"source":{"system":"sec-edgar","filing":"0001683168-25-009112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009112/ownership.xml","form_type":"4"}},{"id":1452870,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:59:12.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":38009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein. This transaction is late due to an inadvertent administrative error and not any error of Mr. Weinstein."}],"balance_after":38009,"derivative":{"exercise_price":2.12,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":38009},"source":{"system":"sec-edgar","filing":"0001683168-24-004918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316824004918/ownership.xml","form_type":"4"}},{"id":1452871,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:58:59.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":38009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker. This transaction is late due to an inadvertent administrative error and not any error of Mr. Walker."}],"balance_after":38009,"derivative":{"exercise_price":2.12,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":38009},"source":{"system":"sec-edgar","filing":"0001683168-24-004917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316824004917/ownership.xml","form_type":"4"}},{"id":1452869,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:58:49.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":38009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter."}],"balance_after":38009,"derivative":{"exercise_price":2.12,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":38009},"source":{"system":"sec-edgar","filing":"0001683168-24-004916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316824004916/ownership.xml","form_type":"4"}},{"id":1452867,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:58:35.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":38009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis."}],"balance_after":38009,"derivative":{"exercise_price":2.12,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":38009},"source":{"system":"sec-edgar","filing":"0001683168-24-004915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316824004915/ownership.xml","form_type":"4"}},{"id":1731601,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:02:21.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":61248,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61248,"derivative":{"exercise_price":2.18,"exercise_date":"2023-11-20","expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":61248},"source":{"system":"sec-edgar","filing":"0001683168-23-008434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008434/ownership.xml","form_type":"4"}},{"id":1731600,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":21803,"kind":"person","name":"WALKER WAYNE REMELL","position":1,"cik":"0001428761","reported_name":"WALKER WAYNE REMELL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:02:03.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":61248,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61248,"derivative":{"exercise_price":2.18,"exercise_date":"2023-11-20","expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":61248},"source":{"system":"sec-edgar","filing":"0001683168-23-008433","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008433/ownership.xml","form_type":"4"}},{"id":1731598,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":108009,"kind":"person","name":"Trujillo Carlos","position":1,"cik":"0001464520","reported_name":"Trujillo Carlos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:01:45.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 50% on November 20, 2023 and 50% on November 20, 2024."}],"balance_after":85000,"derivative":{"exercise_price":2.18,"expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001683168-23-008432","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008432/ownership.xml","form_type":"4"}},{"id":1731599,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":23501,"kind":"person","name":"Silverman Joshua","position":1,"cik":"0001524858","reported_name":"Silverman Joshua","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO, Interim President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:01:23.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 50% on November 20, 2023 and 50% on November 20, 2024."}],"balance_after":170000,"derivative":{"exercise_price":2.18,"expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001683168-23-008431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008431/ownership.xml","form_type":"4"}},{"id":1731597,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:01:06.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":61248,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61248,"derivative":{"exercise_price":2.18,"exercise_date":"2023-11-20","expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":61248},"source":{"system":"sec-edgar","filing":"0001683168-23-008430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008430/ownership.xml","form_type":"4"}},{"id":1731596,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29830,"kind":"person","name":"Abecassis Michael M","position":1,"cik":"0001879281","reported_name":"Abecassis Michael M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:00:10.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":61248,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61248,"derivative":{"exercise_price":2.18,"exercise_date":"2023-11-20","expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":61248},"source":{"system":"sec-edgar","filing":"0001683168-23-008429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008429/ownership.xml","form_type":"4"}},{"id":2074446,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":121229,"kind":"person","name":"Farb Daniel Stuart","position":1,"cik":"0001776353","reported_name":"Farb Daniel Stuart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-30T21:05:56.000Z","date":"2022-12-28","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the \"2022 Plan\"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the \"2022 Plan\"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022."}],"balance_after":125000,"derivative":{"exercise_price":2.97,"exercise_date":"2022-12-28","expiration_date":"2032-11-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001683168-22-008707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316822008707/ownership.xml","form_type":"4"}},{"id":2074444,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":121228,"kind":"person","name":"Allen Daniel","position":1,"cik":"0001736605","reported_name":"Allen Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-30T21:05:37.000Z","date":"2022-12-28","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the \"2022 Plan\"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant was approved by the Issuer's board of directors on November 14, 2022, subject to stockholder approval of the PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan (the \"2022 Plan\"), under which the option was granted. The Issuer's stockholders approved the 2022 Plan on December 28, 2022."}],"balance_after":125000,"derivative":{"exercise_price":2.97,"exercise_date":"2022-12-28","expiration_date":"2032-11-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001683168-22-008706","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316822008706/ownership.xml","form_type":"4"}}]}